Mark A Sirgo

CIK 1301715 · President and CEO · last filed 2023-03-31

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$17.8K

Companies

4

Total Filings

130

Lifetime Open-Market Net

$255.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
9 METERS BIOPHARMA, INC. (NMTR) Delisted Director 86,982 $0.07 $6.3K $949.2K 21 2023-03-31
BMRA Director 8,700 $2.05 $17.8K -$80.9K 8 2021-12-10
SALIX PHARMACEUTICALS LTD (SLXP) Delisted Director 37,427 -$623.2K 23 2014-08-26
BIODELIVERY SCIENCES INTERNATIONAL INC (BDSIW) Delisted President and CEO 819,943 $10.1K 3 2007-06-18

Recent Filings · Page 7 of 13

130 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-03-31 Mixed +413,523 -$210.9K
2017-02-08 Grant (A) $0
2016-08-03 Buy (P) +8,000 $15.7K
2016-08-03 Buy (P) +4,000 $8.2K
2016-03-16 Grant (A) +10,100 $26.6K
2016-03-02 Grant (A) $0
2015-11-30 Exer (M) +49,000 $148.5K
2015-08-19 Exer (M) +20,000 $58.8K
2015-06-17 Mixed +4,002 -$33.4K
2015-04-03 Mixed −37,427 -$6.47M
Showing 6170 of 130
Page 7 of 13
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.